Radiomedix Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Radiomedix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10523
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Radiomedix Inc (Radiomedix) is a biotechnology company that develops and commercializes radiopharmaceuticals for diagnosis and therapy of cancer. The company’s products include radioisotopes, fully automated synthesizers, semi-automated synthesizers, GMP cassettes and consumables, smartmedix system and glucomedix, among others. Radiomedix’s services include radiochemistry and drug design service, CGMP drug manufacturing suite and microPET imaging laboratory. The company has developed its own chelation technology and new imaging conjugates to improve diagnosis and treatment monitoring for a variety of cancers. It also develops radiolabeled agent that targets hedgehog signaling pathway and can be used in diagnosis and staging of lung, ovarian, breast, gastrointestinal, hematological, prostate, skin cancer, and others. The company serves nuclear medicine researchers and clinicians. Radiomedix is headquartered in Houston, Texas, the US.

Radiomedix Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Radiomedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Radiomedix Inc, Medical Devices Deals, 2012 to YTD 2018 9
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Radiomedix Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
RadioMedix Enters into Distribution Agreement with ITG Isotope 11
RadioMedix Enters into Co-Development Agreement with Areva Med 12
RadioMedix Enters Into Distribution Agreement With ITG Isotope Technologies 13
Licensing Agreements 14
Endocyte Receives Rights from Radiomedix 14
Radiomedix Inc – Key Competitors 15
Radiomedix Inc – Key Employees 16
Radiomedix Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Radiomedix Inc, Pharmaceuticals & Healthcare, Key Facts 2
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Radiomedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Radiomedix Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Radiomedix Inc, Medical Devices Deals, 2012 to YTD 2018 9
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
RadioMedix Enters into Distribution Agreement with ITG Isotope 11
RadioMedix Enters into Co-Development Agreement with Areva Med 12
RadioMedix Enters Into Distribution Agreement With ITG Isotope Technologies 13
Endocyte Receives Rights from Radiomedix 14
Radiomedix Inc, Key Competitors 15
Radiomedix Inc, Key Employees 16

List of Figures
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Radiomedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Radiomedix Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Radiomedix Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Epinex Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Epinex Diagnostics Inc (Epinex Diagnostics) is a medical device company that develops rapid diagnostic tests. The company’s products include over-the-counter test device, Epinex G1A Test system, Epinex ACR Test system, Epinex SimplySure PT-INR Test system and point-of-care test device, among …
  • Sharp Corporation (6753):電力:M&Aディール及び事業提携情報
    Summary Sharp Corp (Sharp) designs, develops, and markets digital information equipment, health and environmental equipment, energy and business solutions. The company’s major products are refrigerators, microwave ovens, air conditioners, washing machines, electric fans, beauty appliances, LED light …
  • XsunX Inc (XSNX):企業の財務・戦略的SWOT分析
    XsunX Inc (XSNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bilcare Ltd (526853):企業の財務・戦略的SWOT分析
    Bilcare Ltd (526853) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • PAR Technology Corp (PAR):企業の財務・戦略的SWOT分析
    Summary PAR Technology Corp (PAR) is a technology company that offers systems and solutions for the hospitality industry. The company offers services such as project management, education services, deployment services, on-site field services, depot repair, and managed services. It also implements fo …
  • The Interpublic Group of Companies, Inc.:戦略・SWOT・企業財務分析
    The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Florida Power & Light Co:電力:M&Aディール及び事業提携情報
    Summary Florida Power & Light Company (FPL), a subsidiary of NextEra Energy, Inc., is a vertically-integrated electric utility that generates, transmits and distributes electricity. The company generates electricity from oil, natural gas, coal, nuclear and solar sources. It also purchases power and …
  • Lydall Inc (LDL):企業の財務・戦略的SWOT分析
    Lydall Inc (LDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Atara Biotherapeutics Inc (ATRA):企業の財務・戦略的SWOT分析
    Atara Biotherapeutics Inc (ATRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • PUMA SE:企業の戦略・SWOT・財務情報
    PUMA SE - Strategy, SWOT and Corporate Finance Report Summary PUMA SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • JCB Co., Ltd.:企業の戦略・SWOT・財務情報
    JCB Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary JCB Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Flowserve Corp (FLS):企業の財務・戦略的SWOT分析
    Flowserve Corp (FLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Saft Groupe SA-エネルギー分野:企業M&A・提携分析
    Summary Saft Groupe SA (Saft), a subsidiary of Total SA, is a designer, developer, and manufacturer of batteries. The company provides non-rechargeable and rechargeable batteries thorough nickel, primary lithium, lithium-ion, and other technologies. It offers systems integration, and various turnkey …
  • Sumitomo Metal Mining Co Ltd:企業の戦略・SWOT・財務情報
    Sumitomo Metal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Metal Mining Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Gebr. Heinemann SE & Co. KG:企業の戦略・SWOT・財務情報
    Gebr. Heinemann SE & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Gebr. Heinemann SE & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • British Gas Ltd-エネルギー分野:企業M&A・提携分析
    Summary British Gas Limited (British Gas), a subsidiary of Centrica plc, is an energy utility company that undertakes the distribution of gas and electricity. It supplies electricity and gas to residential retail; commercial wholesale; and small, medium and large industrial customers. The company al …
  • Reliv International Inc (RELV):企業の財務・戦略的SWOT分析
    Summary Reliv International Inc (Reliv) is a nutrition company that develops, manufactures and markets nutritional supplements for basic nutrition, specific wellness needs, weight management and sports nutrition. The company’s products include Reliv Classic and Reliv NOW, a nutritional supplement wi …
  • The Sherwin-Williams Company:企業の戦略・SWOT・財務分析
    The Sherwin-Williams Company - Strategy, SWOT and Corporate Finance Report Summary The Sherwin-Williams Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Mettler-Toledo International Inc:企業の戦略・SWOT・財務分析
    Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report Summary Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Empresas Publicas De Medellin ESP:電力:M&Aディール及び事業提携情報
    Summary Empresas Publicas De Medellin ESP (EPM) is a decentralized body, operational under the ownership of Medellin municipality. It generates, transmits, and distributes electricity as well as undertakes gas distribution, wastewater and garbage treatment, and telecommunications services across the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆